Head-to-head comparison
Epithalon vs Rapamycin
Physician-reviewed comparison
Epithalon
Emerging ResearchResearch Only
Synthetic tetrapeptide researched for telomerase activation and cellular aging effects.
Rapamycin
Peer ReviewedFDA Approved
An mTOR inhibitor FDA-approved as an immunosuppressant, now studied for longevity applications.
Quick Comparison
| Dimension | Epithalon | Rapamycin |
|---|---|---|
| Category | longevity | longevity |
| Classification | Synthetic Tetrapeptide | mTOR Inhibitor (Macrolide) |
| Evidence Rating | Emerging Research | Peer Reviewed |
| Regulatory Status | Research Only | FDA Approved |
| Delivery | Subcutaneous injection | Oral tablet, Topical cream |
| Complexity | 4 / 5 | 4 / 5 |
| Refrigeration | Required | Not required |
Dosing Comparison
Epithalon
Longevity (Russian Protocol)
10–10 mg · daily
Rapamycin
Longevity (Intermittent)
1–6 mg · weekly
Transplant Immunosuppression (FDA-Approved)
2–15 mg · daily
Can You Stack Them?
No known direct interaction between Epithalon and Rapamycin in our database. However, always consult your provider before combining compounds.
Medical Disclaimer
This comparison is for educational purposes only. Individual responses vary. Consult a qualified healthcare provider before using any compound.